Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDF) are carefully selected to provide our customers with a competitive market position by delivering a unique IP as part of a total solution. All these products comply with the exacting regulatory requirements of leading health authorities, including the FDA, MCA, TGA and HPB.
| Product | therapeutic use |
|---|---|
| Anastrozole | Non-steroidal aromatase inhibitor |
| Cetirizine Dihydrochloride | Non-sedative antihistamine |
| Cilostazol | Antithrombotic |
| Disodium pamoate monohydrate | Alkylating agent |
| Donepezil Hydrochloride | Antialzheimer, Cognition enhancer |
| Exemestane | Steroidal aromatase inhibitor |
| Fenofibrate | Antihyperlipoproteinemic |
| Flumazenil | Benzodiazepine antagonist |
| Fluticasone Propionate | Antiallergic agent, Antiinflammatory |
| Gemcitabine Hydrochloride | Antimetabolite, Antineoplastic |
| Granisetron Hydrochloride | Antiemetic, Antinauseant |
| Imiquimod | Immune response modifier |
| Lamotrigine | Antiepileptic |
| Letrozole | Non-steroidal aromatase inhibitor |
| Levocetirizine Dihydrochloride | Non-sedative antihistamine |
| Midazolam Base | Anesthetic, Central nervous system depressant, Sleeping aid |
| Midazolam HCl | Anesthetic, Central nervous system depressant, Sleeping aid |
| Midazolam Maleate | Anesthetic, Central nervous system depressant, Sleeping aid |
| Modafinil | Antinarcoleptic |
| Mometasone Furoate | Antiinflammatory |
| Montelukast Sodium | Prophylaxis of asthma |
| Moxonidine | Antihypertensive |
| Pentoxifylline | Vasodilator |
| Pramipexole Dihydrochloride | Antiparkinsonian |
| R-Modafinil | Antinarcoleptic |
| Rocuronium Bromide | Neuromuscular blocker |
| Temozolomide | Alkylating agent, Antineoplastic |
| Terbinafine Hydrochloride | Antidermatophyte (fungal infections of the nails) |
| Tramadol Hydrochloride | Analgesic |
| Zonisamide | Antiepileptic |
